Profil
Karin Hoogendoorn is currently a Director at the Centre For Advanced Medical Products.
Previously, she worked as an Associate Director at Novartis AG and Janssen Biologics BV.
She also served as a Director at Idogen AB and an Independent Director at Elicera Therapeutics AB. Additionally, she was the Head of Chemistry, Manufacturing & Controls at Mendus AB. Dr. Hoogendoorn holds a graduate degree from the University of Leiden and a doctorate degree from the University of Utrecht.
Postes actifs de Karin Hoogendoorn
| Sociétés | Poste | Début |
|---|---|---|
Centre For Advanced Medical Products | Directeur/Membre du Conseil | - |
Anciens postes connus de Karin Hoogendoorn
| Sociétés | Poste | Fin |
|---|---|---|
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Directeur/Membre du Conseil | 12/05/2020 |
| ELICERA THERAPEUTICS AB | Directeur/Membre du Conseil | - |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Manufactures, acquires and markets biopharmaceutical therapies | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
| MENDUS AB | Corporate Officer/Principal | - |
Formation de Karin Hoogendoorn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Manufactures, acquires and markets biopharmaceutical therapies | Health Technology |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
Elicera Therapeutics AB
Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
Centre For Advanced Medical Products |
















